15 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33574948 | Identification of AKT1/β-catenin mutations conferring cetuximab and chemotherapeutic drug resistance in colorectal cancer treatment. | 2021 Mar | 1 |
2 | 33578797 | SILAC-Based Quantitative Proteomic Analysis of Oxaliplatin-Resistant Pancreatic Cancer Cells. | 2021 Feb 10 | 1 |
3 | 34539880 | Inositol hexaphosphate sensitizes hepatocellular carcinoma to oxaliplatin relating inhibition of CCN2-LRP6-β-catenin-ABCG1 signaling pathway. | 2021 | 2 |
4 | 34688609 | CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism. | 2021 Dec 1 | 1 |
5 | 32652867 | Knockdown of DNA-binding protein A enhances the chemotherapy sensitivity of colorectal cancer via suppressing the Wnt/β-catenin/Chk1 pathway. | 2020 Oct | 1 |
6 | 32657048 | Combination treatment with artemisinin and oxaliplatin inhibits tumorigenesis in esophageal cancer EC109 cell through Wnt/β-catenin signaling pathway. | 2020 Aug | 2 |
7 | 30539797 | miR-122 enhances sensitivity of hepatocellular carcinoma to oxaliplatin via inhibiting MDR1 by targeting Wnt/β-catenin pathway. | 2019 Feb | 2 |
8 | 30859572 | Hypermethylated and downregulated MEIS2 are involved in stemness properties and oxaliplatin-based chemotherapy resistance of colorectal cancer. | 2019 Aug | 1 |
9 | 30965636 | A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS. | 2019 Apr 8 | 1 |
10 | 28217977 | miR-506 enhances the sensitivity of human colorectal cancer cells to oxaliplatin by suppressing MDR1/P-gp expression. | 2017 Jun | 1 |
11 | 28373425 | ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells. | 2017 Apr | 1 |
12 | 28621236 | Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial. | 2017 Jun | 1 |
13 | 27609465 | Upregulation of CYP2S1 by oxaliplatin is associated with p53 status in colorectal cancer cell lines. | 2016 Sep 9 | 1 |
14 | 23504997 | Suppression of actopaxin impairs hepatocellular carcinoma metastasis through modulation of cell migration and invasion. | 2013 Aug | 1 |
15 | 20980803 | Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death. | 2011 Jan 1 | 6 |